← Top stories
Expansion● Neutral for Indian equities
India has biotech talent and know-how, but funding ecosystem lags: Lilly CEO
The brief
- Eli Lilly plans to launch up to four new weight-loss products in coming years
- The summary cites the success of Mounjaro and Zepbound
- India’s biotech funding gap matters to domestic pharma and biotech companies seeking to develop new treatments